SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000935836-21-000445
Filing Date
2021-07-29
Accepted
2021-07-28 18:52:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 kezar13g.htm SC 13G 59433
  Complete submission text file 0000935836-21-000445.txt   60959
Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Subject) CIK: 0001645666 (see all company filings)

IRS No.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90539 | Film No.: 211124158
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 LETTERMAN DRIVE STE. D3-700 SAN FRANCISCO CA 94129
Business Address 1 LETTERMAN DRIVE STE. D3-700 SAN FRANCISCO CA 94129 4158014660
Logos Global Management LP (Filed by) CIK: 0001792126 (see all company filings)

IRS No.: 833997742 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G